Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

CV Sciences (CVSI) Capital Expenditures (2016 - 2025)

CV Sciences' Capital Expenditures history spans 11 years, with the latest figure at $9000.0 for Q4 2025.

On a quarterly basis, Capital Expenditures fell 50.0% to $9000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $109000.0, a 505.56% increase, with the full-year FY2025 number at $109000.0, up 505.56% from a year prior.
Capital Expenditures hit $9000.0 in Q4 2025 for CV Sciences, down from $11000.0 in the prior quarter.
Over the last five years, Capital Expenditures for CVSI hit a ceiling of $49000.0 in Q2 2025 and a floor of $9000.0 in Q4 2025.
Historically, Capital Expenditures has averaged $27000.0 across 3 years, with a median of $26500.0 in 2021.
Biggest five-year swings in Capital Expenditures: tumbled 53.95% in 2021 and later crashed 50.0% in 2025.
Tracing CVSI's Capital Expenditures over 3 years: stood at $35000.0 in 2021, then tumbled by 48.57% to $18000.0 in 2024, then crashed by 50.0% to $9000.0 in 2025.
Business Quant data shows Capital Expenditures for CVSI at $9000.0 in Q4 2025, $11000.0 in Q3 2025, and $49000.0 in Q2 2025.